HeartBeam Inc. (NASDAQ: BEAT) announced it will host a conference call on March 12, 2026, at 4:30 p.m. Eastern time to discuss financial results for the fourth quarter and full year ended December 31, 2025. The call will also provide updates on key strategic growth initiatives, including the limited commercial launch and progress on its 12-lead ECG extended wear patch. A press release detailing the results will be issued prior to the call, available at https://ibn.fm/sLaxc.
The importance of this announcement lies in HeartBeam's ongoing development of technology that could redefine cardiac health management. The company is creating the first cable-free device capable of collecting electrocardiogram (ECG) signals in three dimensions from non-coplanar directions and synthesizing them into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever a patient is located, delivering actionable heart intelligence to physicians.
For the medical industry and patients, the implications are significant. Physicians could potentially identify cardiac health trends and acute conditions outside traditional medical facilities, directing patients to appropriate care more efficiently. HeartBeam's 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, and the 12-lead ECG synthesis software received clearance in December 2025. The intended use details of this technology are outlined in the company's Cleared Indications for Use at https://www.heartbeam.com/indications.
The upcoming conference call will provide investors and stakeholders with insights into the company's financial health and commercialization progress. HeartBeam holds over 20 issued patents related to its technology enablement, positioning it as a potential innovator in the cardiac care space. The limited commercial launch of its extended wear patch represents a critical step toward broader market adoption.
For those following the company's developments, additional news and updates relating to BEAT are available in the company's newsroom at https://ibn.fm/BEAT. The conference call will offer a comprehensive view of how HeartBeam is progressing toward its goal of transforming cardiac care through advanced, portable technology that moves diagnosis and monitoring beyond hospital settings.
